ABSTRACT Tracheobronchial clearance was measured by a radioaerosol technique in 12 patients with bronchiectasis, seven patients with chronic obstructive lung disease expectorating mucoid sputum daily (group X), eight patients with chronic obstructive lung disease but negligible sputum expectoration (group Y), and 10 healthy subjects. The patients with bronchiectasis all expectorated purulent sputum daily (mean wet weight 47 g/day), had reduced forced expiratory volume in one second (FEV1) (mean 47 5% predicted), and were unable to avoid coughing during the six hour observation period. None of the patients with bronchiectasis or the healthy subjects were current smokers. There were five current smokers in group X and six in group Y. The mean FEV1 in group X was 41% predicted and in group Y 52% predicted, both values similar to that of the patients with bronchiectasis.
Clearance of microbes and host derived inflammatory products from the lungs of patients with bronchiectasis is important if the vicious circle of microbial colonisation and host response that may lead to progression of lung damage is to be avoided. ' Only one previous study2 has reported impaired lung mucociliary clearance in patients with bronchiectasis (these did not have clinical Kartagener's syndrome but were not tested for a primary ciliary dyskinesia). The clearance rates of inhaled particles in that study were similar to those in patients with chronic bronchitis. Clearance was impaired in six of the patients with bronchiectasis and mild airways obstruction (mean FEV, 70% predicted) by com- parison with that in normal subjects but, surprisingly, in the other eight patients with bronchiectasis, who had more severe symptoms and greater airways obstruction (mean FEV1 50% predicted), it was not shown to be significantly impaired.
Because of this discrepancy we measured the lung deposition and clearance on inhaled radioaerosol in a Address for reprint requests: Dr D C Currie, Host Defence Unit, Cardiothoracic Institute, London SW3 6HP.
Accepted 18 August 1986 group of 12 patients with bronchiectasis and considerable airways obstruction and compared these with the deposition and clearance in patients with chronic obstructive lung disease but no bronchiectasis and in healthy subjects.
Methods

PATIENTS
Three groups of patients and one control group were studied. Group B-Twelve patients (seven of them men) with radiologically definite bronchiectasis who were expectorating purulent sputum daily. Seven were exsmokers and had not smoked for 8-25 years and five were lifelong non-smokers. Group X-Seven men with chronic obstructive lung disease with no evidence of bronchiectasis on plain chest radiographs who were expectorating mucoid sputum daily. Five were smokers and two were exsmokers. Group Y-Eight patients (six of them men) with chronic obstructive lung disease but negligible sputum expectoration, with no evidence of bronchiectasis on plain chest radiographs. Six were smokers and two ex-smokers. 126 Impaired tracheobronchial clearance in bronchiectasis Control group-Ten healthy subjects (five of them men) matched with group B for age, sex, height, weight, and inspiratory flow rate of radioaerosol. Two were ex-smokers and eight were lifelong nonsmokers.
The characteristics of each group are shown in table 1.
The patients in group B had moderately severe bronchiectasis as judged by the extent of their disease on computed tomography scans3 (median 3 lobes), 24 hour sputum production (range 20-120g) and reduced FEV1 (range 17-91% predicted). 4 The median duration of daily sputum production was 45 years (range 10->60). Haemophilus influenzae was isolated from the sputum in 11 of the patients, Pseudomonas aeruginosa in three patients, and Staphylococcus aureus in one patient. One patient had associated rheumatoid arthritis, two had azoospermia and 10 reported nasal symptoms. Nasal mucociliary clearance by the saccharin method' was longer than 60 minutes in three patients and a mean of 28 minutes in the remainder. The three patients with prolonged clearance all had normal ciliary beat frequencies.
TECHNIQUE
A non-invasive radioaerosol technique was used to measure tracheobronchial clearance. 6 The subjects inhaled polystyrene particles of 5 gm diameter, labelled firmly with technetium-99m (99mTc), according to a standard protocol.7 The radioaerosol initially deposited in the lungs was measured and its subsequent clearance was monitored by two scintillation counters located opposite each other anterior and posterior to the chest. All radiation counts were corrected for background radiation and physical decay of the radionuclide. A final count was carried out at 48 hours in 10 of the 12 patients with bronchiectasis and at 24 hours in the remaining subjects. The amount of alveolar deposition was defined as the amount of radioactivity remaining at the time of the last count (24 or 48 hours). These particles were assumed to be unavailable for tracheobronchial clearance, and were subtracted from the total lung burden to yield the total amount of radioaerosol available for tracheobronchial clearance. All counts were expressed as percentages of the initial count to overcome unavoidable differences between subjects in the initial total lung burden of radioaerosol. The remaining amount of radioaerosol available for tracheobronchial clearance was measured at regular intervals for the first six hours. The reading at six hours (TBC6) was used as a measure of this clearance. These data were also displayed graphically and a second measure of total clearance of radioaerosol was obtained by calculating the area under the curve (AUC), with the use of the trapezoidal rule, for the six hours. The lower the value of TBC6 or AUC the greater the tracheobronchial clearance (for example, with no clearance TBC6 = 100, AUC = 600).
Informed written consent was obtained from all the subjects before the test. They were asked to omit all theophylline preparations and oral f#2 agonists for the 12 hours before the test. The initial lung burden per study amounted to about 30,pCi (1-1 MBq) of 99mTc, resulting in an absorbed radiation dose to the lungs of the order of 12mrem (0-12mSv). The mean inspiratory flow rate for each group of patients was similar (table 1) .
The number of coughs, wet weight of sputum expectorated, and amount of radioaerosol in the expectorated sputum during the six hour test period were measured. The amount of radioaerosol in the sputum was expressed as a percentage of the initial radioaerosol available for tracheobronchial clearance. The data werenot normally distributed and statistical significance was assessed by the non-parametric Wilcoxon rank sum test for unpaired data.8
Results
The results for the three groups of patients and the 127 The patients with bronchiectasis (group B) and those with chronic obstructive lung disease and regular sputum production (group X) were unable to avoid coughirng during the test. Unfortunately the amount of radioaerosol expectorated in the sputum is simply a measure of the amount of airway mucus not swallowed and does not equal the proportion of the tracheobronchial clearance which is effected by coughing. Therefore the precise proportion of tracheobronchial clearance attributable to each of the two components of clearance-mucociliary clearance and cough is unknown in these two groups (B and X), but, given that some of their tracheobronchial clearance is due to coughing, these two groups must have worse mucociliary clearance than the group of patients with chronic obstructive lung disease and negligible sputum (group Y).
The fact that patients with bronchiectasis have greater impairment of mucociliary clearance than older patients with chronic obstructive lung disease without sputum is probably due to differences in the type and pattern of bronchial damage and in the characteristics of the secretions-in particular the presence of irreversible bronchial dilatation and continuous purulent sputum production in our patients with bronchiectasis. Both anatomical disorganisation and possible damage to bronchial ciliated epithelium may impair clearance in patients with bronchiectasis. In patients with primary ciliary dyskinesia, no appreciable mucociliary clearance has been detected, '7 18 and mucociliary clearance is impaired in Polynesian patients with bronchiectasis associated with apparent ciliary abnormalities.'9 Pathological changes in the bronchi of non-bronchiectatic segments of the patients with bronchiectasis may also appreciably alter the clearance of radioaerosol. The regional clearance in these patients is being assessed. The purulent sputum produced by the patients with bronchiectasis contained copious white blood cells, bacteria, and their products (including elastase). Such secretions have been shown to impair normal human ciliary function in vitro.20 Neutrophil elastase2' and bacterial products22 damage human ciliated epithelium and reduce ciliary beat frequency in vitro. Furthermore, nasal cilia bathed in purulent secretions in vivo from patients with sinusitis beat more slowly in vitro than those obtained from healthy subjects.23 In contrast, the patients with chronic bronchitis had less bronchial damage and mucoid sputum. D C was supported by the Chest, Heart, and Stroke Association and aspects of this research were supported by the National Fund for Research into Crippling Diseases.
